Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial

PURPOSE. To investigate the safety and effects of intravitreal sirolimus for the potential treatment of geographic atrophy (GA). METHODS. The study was a single-center, open-label, phase I/II trial enrolling six participants with bilateral GA treated with intravitreal sirolimus in only one randomly...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Invest Ophthalmol Vis Sci
Päätekijät: Petrou, Philip A., Cunningham, Denise, Shimel, Katherine, Harrington, Molly, Hammel, Keri, Cukras, Catherine A., Ferris, Frederick L., Chew, Emily Y., Wong, Wai T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Association for Research in Vision and Ophthalmology 2015
Aiheet:
Clinical Trials
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4294293/
https://ncbi.nlm.nih.gov/pubmed/25525171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.14-15877
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia